Literature DB >> 17358006

Sympathetic neural activity, sex dimorphism, and postural tachycardia syndrome.

Istvan Bonyhay1, Roy Freeman.   

Abstract

OBJECTIVE: To elucidate the mechanisms whereby postural tachycardia syndrome (POTS) patients maintain orthostatic blood pressure and explain the greater prevalence of female cases in POTS cohorts.
METHODS: We investigated muscle sympathetic nerve (MSN) discharge characteristics in 12 female POTS patients and in 9 male and 12 female control subjects using the burst amplitude distribution and the relative contribution of burst frequency and burst amplitude.
RESULTS: At rest, burst distribution was shifted toward larger amplitudes in POTS patients (p < 0.005), consistent with increased sympathetic activity. During hypotension, the distribution shifted toward larger amplitude bursts in control subjects (p < 0.001), whereas it did not change in POTS patients. Total MSN activity increase to hypotension did not differ between subject groups, but the relative contribution of burst frequency change to the total activity increase was greater in POTS patients than in female (p < 0.05) and male (p < 0.001) control subjects. In contrast, the relative contribution of burst amplitude change to total MSN activity increase was greater in male compared with female control subjects (p < 0.05) and POTS patients (p < 0.001).
INTERPRETATION: At rest, the burst amplitude distribution was consistent with increased sympathetic activity in POTS and did not change in response to hypotension. In response to hypotension, burst frequency makes a proportionally greater contribution to the increase in total MSN activity in POTS patients compared with female control subjects, and female compared with male control subjects. These physiological differences in MSN discharge characteristics, in the setting of sympathetic fiber loss associated with POTS, may contribute to the predisposition to and greater prevalence of POTS in female individuals.

Entities:  

Mesh:

Year:  2007        PMID: 17358006     DOI: 10.1002/ana.21090

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  7 in total

1.  Ascorbate improves circulation in postural tachycardia syndrome.

Authors:  Julian M Stewart; Anthony J Ocon; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-27       Impact factor: 4.733

2.  Postural tachycardia syndrome with asystole on head-up tilt.

Authors:  Amer Alshekhlee; Meziane Guerch; Faisal Ridha; Kevin Mcneeley; Thomas C Chelimsky
Journal:  Clin Auton Res       Date:  2007-10-19       Impact factor: 4.435

3.  Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome.

Authors:  Julian M Stewart; Anthony J Ocon; Debbie Clarke; Indu Taneja; Marvin S Medow
Journal:  Hypertension       Date:  2009-03-16       Impact factor: 10.190

4.  Reduced central blood volume and cardiac output and increased vascular resistance during static handgrip exercise in postural tachycardia syndrome.

Authors:  Julian M Stewart; Indu Taneja; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-07-06       Impact factor: 4.733

5.  Lower urinary tract dysfunction in patients with dysautonomia.

Authors:  Melissa St Aubin; Anand Shridharani; Alexandru C Barboi; Michael L Guralnick; Safwan S Jaradeh; Thomas E Prieto; R Corey O'Connor
Journal:  Clin Auton Res       Date:  2015-11-03       Impact factor: 4.435

6.  Structural and functional small fiber abnormalities in the neuropathic postural tachycardia syndrome.

Authors:  Christopher H Gibbons; Istvan Bonyhay; Adam Benson; Ningshan Wang; Roy Freeman
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

Review 7.  Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment.

Authors:  Brian Olshansky; David Cannom; Artur Fedorowski; Julian Stewart; Christopher Gibbons; Richard Sutton; Win-Kuang Shen; James Muldowney; Tae Hwan Chung; Suzy Feigofsky; Hemal Nayak; Hugh Calkins; David G Benditt
Journal:  Prog Cardiovasc Dis       Date:  2020-03-25       Impact factor: 11.278

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.